Literature DB >> 16484238

Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.

Eun-Young Lee1, Choon Hee Chung, Jung Hyun Kim, Hea-Jung Joung, Sae Yong Hong.   

Abstract

BACKGROUND: The increased production of reactive oxygen species (ROS) may be involved in the onset or development of diabetic vascular complications. The release of ROS from podocytes plays a role in the pathogenesis of glomerular damage in various experimental glomerular diseases. Although it is assumed that the podocyte injury also plays an important role in diabetic nephropathy, the mechanism is still unknown.
METHODS: Using a differentiated mouse podocyte cell line, we investigated: (1) whether a high level of ambient glucose increases the level of ROS, (2) whether the protein kinase C (PKC) pathway is involved in a high-glucose-induced generation of ROS and vascular endothelial growth factor (VEGF) and (3) whether antioxidants ameliorate PKC-mediated VEGF expression in diabetic milieu.
RESULTS: Intracellular ROS generation was significantly higher in high glucose than in control conditions in cultured podocytes. High ambient glucose also increased VEGF mRNA and protein expression. The high-glucose-induced increases in ROS and VEGF mRNA and protein by podocytes were effectively inhibited by pretreatment with various antioxidants and were completely restored by PKC inhibition. The results show that cultured mouse podocytes produce ROS in response to high glucose, and that PKC is involved in high-glucose-induced ROS and VEGF production by podocyte.
CONCLUSION: Increased ROS in podocytes may play a role in the pathogenesis of podocyte injury in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484238     DOI: 10.1093/ndt/gfl022

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes.

Authors:  Ran Choi; Bo Hwan Kim; Jarinyaporn Naowaboot; Mi Young Lee; Mi Ri Hyun; Eun Ju Cho; Eun Soo Lee; Eun Young Lee; Young Chul Yang; Choon Hee Chung
Journal:  Exp Mol Med       Date:  2011-12-31       Impact factor: 8.718

2.  Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus.

Authors:  Ping-Ping Dong
Journal:  J Clin Lab Anal       Date:  2018-10-23       Impact factor: 2.352

3.  Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus.

Authors:  P Wei; P R Grimm; D C Settles; C R Balwanz; B J Padanilam; S C Sansom
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

4.  The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.

Authors:  Eun Young Lee; Choon Hee Chung; Charbel C Khoury; Tet Kin Yeo; Petr E Pyagay; Amy Wang; Sheldon Chen
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-06

5.  Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.

Authors:  Chinedu Njoku; Sally E Self; Philip Ruiz; Ann F Hofbauer; Gary S Gilkeson; Jim C Oates
Journal:  J Investig Med       Date:  2008-10       Impact factor: 2.895

6.  Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants.

Authors:  Jakob Fay; Deike Varoga; Christoph J Wruck; Bodo Kurz; Mary B Goldring; Thomas Pufe
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 7.  Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy.

Authors:  Choon Hee Chung; Jingyi Fan; Eun Young Lee; Jeong Suk Kang; Seung Joo Lee; Petr E Pyagay; Charbel C Khoury; Tet-Kin Yeo; Mark F Khayat; Amy Wang; Sheldon Chen
Journal:  Nephron Extra       Date:  2015-02-04

8.  Effects of extremely low frequency pulsed magnetic fields on diabetic nephropathy in streptozotocin-treated rats.

Authors:  Feijiang Li; Tao Lei; Kangning Xie; Xiaoming Wu; Chi Tang; Maogang Jiang; Juan Liu; Erping Luo; Guanghao Shen
Journal:  Biomed Eng Online       Date:  2016-01-19       Impact factor: 2.819

Review 9.  Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury.

Authors:  Selim Fakhruddin; Wael Alanazi; Keith E Jackson
Journal:  J Diabetes Res       Date:  2017-01-09       Impact factor: 4.011

10.  Apelinergic system in the kidney: implications for diabetic kidney disease.

Authors:  Tilman Müller; Anastasia Z Kalea; Alonso Marquez; Ivy Hsieh; Syed Haque; Minghao Ye; Jan Wysocki; Michael Bader; Daniel Batlle
Journal:  Physiol Rep       Date:  2018-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.